AN ACT relating to coverage for COVID-19 testing.

Create new section of Subtitle 17A of KRS Chapter 304 to require health benefit plans to provide coverage for polymerase chain reaction testing used to detect the COVID-19 virus; amend KRS 164.2871, 18A.225, 205.522, and 205.6485 to require self-insured employer group plans provided by the governing board of a state postsecondary education institution, the state employee health plan, Medicaid, and KCHIP to comply with the coverage requirement for polymerase chain reaction testing used to detect the COVID-19 virus; provide that various sections apply to health benefit plans issued or renewed on or after January 1, 2026; require the Department for Medicaid Services or the Cabinet for Health and Family Services to obtain federal approval, if necessary, and comply with notice requirements; EFFECTIVE, in part, January 1, 2026.